Sofwave Medical Ltd SOFW

Morningstar Rating

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SOFW is trading at a LOCK|j>?q? premium.
Price
₪34.96
Fair Value
LOCK|.TF%sHq#
Uncertainty
LOCK|h?
1-Star Price
LOCK|.PnyM$W<
5-Star Price
LOCK|.w>s>?@$
Economic Moat
LOCK|dvhl
Capital Allocation
—

News

Trading Information

Previous Close Price
—
Day Range
—–—
52-Week Range
—–—
Bid/Ask
— / —
Shares Outstanding
36.39M
Market Cap
—
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
47.54
Price/Sales
4.13
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. SUPERB, Synchronous Ultrasound Parallel Beam technology, is the company's FDA-cleared technology to improve facial lines and wrinkles, lift the eyebrows and lax submental tissue (beneath the chin), lift lax skin in the arms, and provide short-term improvement in the appearance of cellulite and treatment of acne scars. Its Pure Impact module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with effective and safe aesthetic solutions for their patients. Geographically, it generates maximum revenue from the United States, followed by East Asia, Europe and the Middle East, and other regions.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
151

Valuation

Metric
SOFW
Price/Earnings (Normalized)
47.54
Price/Book Value
14.05
Price/Sales
4.13
Price/Cash Flow
31.02
Price/Earnings
SOFW

Financial Strength

Metric
SOFW
Quick Ratio
1.95
Current Ratio
2.71
Interest Coverage
32.73
Quick Ratio
SOFW

Profitability

Metric
SOFW
Return on Assets (Normalized)
22.38%
Return on Equity (Normalized)
59.13%
Return on Invested Capital (Normalized)
32.90%
Return on Assets
SOFW

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|NT&%BT^LOCK|YG&%P$188B
Medtronic PLC
MDT
LOCK|d&?&KQLOCK|kY<LD$132B
Stryker Corp
SYK
LOCK|yh><x^<LOCK|jN$118B
Boston Scientific Corp
BSX
LOCK|bqddmsLOCK|>>t&$64B
Edwards Lifesciences Corp
EW
LOCK|Yk#@t?>LOCK|fh%P$62B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|MvrG>PLOCK|Qb$38B
DexCom Inc
DXCM
LOCK|tQMXdd@LOCK|?Fy^$31B
Koninklijke Philips NV ADR
PHG
LOCK|<c!LOCK|%!@$30B
Steris PLC
STE
LOCK|##&Bvz#LOCK|$#&<s$26B
Zimmer Biomet Holdings Inc
ZBH
LOCK|?Prz#MhsLOCK|!&Z$20B

Sponsor Center